AAA Robert Lavine – Page 40

Xeris formulates $75m IPO filing

Medicine producer Institut Mérieux is in line for an exit from US-based drug formulation developer Xeris Pharmaceuticals, which has filed to raise up to $75m in an initial public offering. Xeris is working on injectable and infusible drug formulations based on its formulation technology platforms, XeriSol and XeriJect. Its lead product is a ready-to-use pen… Continue reading Xeris formulates $75m IPO filing